{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T19:58:17Z","timestamp":1777924697639,"version":"3.51.4"},"reference-count":24,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Amsen"},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002491","name":"Bristol-Myers Squibb","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"publisher"}]},{"name":"MSD-Merck"},{"name":"Merck-Pfizer"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.jaad.2019.01.042","type":"journal-article","created":{"date-parts":[[2019,1,29]],"date-time":"2019-01-29T10:49:53Z","timestamp":1548758993000},"page":"977-983","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Treatment and survival of Merkel cell carcinoma since 1993: A population-based cohort study in The Netherlands"],"prefix":"10.1016","volume":"81","author":[{"given":"Sanne E.","family":"Uitentuis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marieke W.J.","family":"Louwman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander C.J.","family":"van Akkooi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcel W.","family":"Bekkenk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jaad.2019.01.042_bib1","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1001\/archderm.1972.01620040075020","article-title":"Trabecular carcinoma of the skin","volume":"105","author":"Toker","year":"1972","journal-title":"Arch Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2019.01.042_bib2","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/j.1600-0560.2009.01370.x","article-title":"Merkel cell carcinoma demographics, morphology, and survival based on 3870 cases: a population based study","volume":"37","author":"Albores-Saavedra","year":"2010","journal-title":"J Cutan Pathol"},{"issue":"3","key":"10.1016\/j.jaad.2019.01.042_bib3","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.jaad.2017.10.028","article-title":"Merkel cell carcinoma: current United States incidence and projected increases based on changing demographics","volume":"78","author":"Paulson","year":"2017","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2019.01.042_bib4","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.ejca.2010.11.002","article-title":"Epidemiology and survival of Merkel cell carcinoma in The Netherlands. A population-based study of 808 cases in 1993-2007","volume":"47","author":"Reichgelt","year":"2011","journal-title":"Eur J Cancer"},{"issue":"8","key":"10.1016\/j.jaad.2019.01.042_bib5","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1001\/jamadermatol.2014.124","article-title":"Incidence and survival for Merkel cell carcinoma in Queensland, Australia, 1993-2010","volume":"150","author":"Youlden","year":"2014","journal-title":"JAMA Dermatol"},{"issue":"10","key":"10.1016\/j.jaad.2019.01.042_bib6","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1111\/jdv.13698","article-title":"Merkel cell carcinoma incidence is increasing in Sweden","volume":"30","author":"Zaar","year":"2016","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"5","key":"10.1016\/j.jaad.2019.01.042_bib7","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/S0190-9622(03)02108-X","article-title":"Epidemiology of primary Merkel cell carcinoma in the United States","volume":"49","author":"Agelli","year":"2003","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2019.01.042_bib8","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1097\/00000421-200202000-00011","article-title":"Role of postoperative radiotherapy in the management of Merkel cell carcinoma","volume":"25","author":"Eich","year":"2002","journal-title":"Am J Clin Oncol"},{"issue":"4","key":"10.1016\/j.jaad.2019.01.042_bib9","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1017\/S0022215116000153","article-title":"Merkel cell carcinoma of the head and neck: poorer prognosis than non-head and neck sites","volume":"130","author":"Morand","year":"2016","journal-title":"J Laryngol Otol"},{"issue":"3","key":"10.1016\/j.jaad.2019.01.042_bib10","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.jaad.2012.09.036","article-title":"Prognostic factors in Merkel cell carcinoma: analysis of 240 cases","volume":"68","author":"Tarantola","year":"2013","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2019.01.042_bib11","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.jaad.2007.11.020","article-title":"Clinical characteristics of Merkel cell carcinoma at diagnosis in 195 patients: the AEIOU features","volume":"58","author":"Heath","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2019.01.042_bib12","article-title":"Adjuvant radiation therapy and chemotherapy in Merkel cell carcinoma: survival analysis of 6,908 cases from the National Cancer Data Base","volume":"1","author":"Bhatia","year":"2014","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.jaad.2019.01.042_bib13","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1001\/jamaoto.2014.3052","article-title":"The role of adjuvant therapy in the management of head and neck merkel cell carcinoma: an analysis of 4815 patients","volume":"141","author":"Chen","year":"2015","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"issue":"6","key":"10.1016\/j.jaad.2019.01.042_bib14","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1001\/archderm.142.6.693","article-title":"Adjuvant local irradiation for Merkel cell carcinoma","volume":"142","author":"Lewis","year":"2006","journal-title":"Arch Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2019.01.042_bib15","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1445-2197.2005.03353.x","article-title":"Merkel cell carcinoma: improved outcome with adjuvant radiotherapy","volume":"75","author":"Veness","year":"2005","journal-title":"ANZ J Surg"},{"issue":"2","key":"10.1016\/j.jaad.2019.01.042_bib16","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/bjd.14240","article-title":"Sentinel lymph node biopsy in Merkel cell carcinoma: a 15-year institutional experience and statistical analysis of 721 reported cases","volume":"174","author":"Gunaratne","year":"2016","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2019.01.042_bib17","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.jaad.2017.12.004","article-title":"Merkel cell carcinoma: an update and review: current and future therapy","volume":"78","author":"Tello","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2019.01.042_bib18","series-title":"Cancer Incidence in Five Continents","author":"Waterhouse","year":"1976"},{"issue":"1","key":"10.1016\/j.jaad.2019.01.042_bib19","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/sim.1597","article-title":"Regression models for relative survival","volume":"23","author":"Dickman","year":"2004","journal-title":"Stat Med"},{"issue":"2","key":"10.1016\/j.jaad.2019.01.042_bib20","first-page":"427","article-title":"Cytokeratin 20 in human carcinomas. A new histodiagnostic marker detected by monoclonal antibodies","volume":"140","author":"Moll","year":"1992","journal-title":"Am J Pathol"},{"issue":"2","key":"10.1016\/j.jaad.2019.01.042_bib21","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1097\/00000478-199702000-00014","article-title":"Cytokeratin 20 immunoreactivity distinguishes Merkel cell (primary cutaneous neuroendocrine) carcinomas and salivary gland small cell carcinomas from small cell carcinomas of various sites","volume":"21","author":"Chan","year":"1997","journal-title":"Am J Surg Pathol"},{"issue":"8","key":"10.1016\/j.jaad.2019.01.042_bib22","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1002\/jso.25090","article-title":"Merkel cell carcinoma: clinical outcome and prognostic factors in 351 patients","volume":"117","author":"van Veenendaal","year":"2018","journal-title":"J Surg Oncol"},{"issue":"10","key":"10.1016\/j.jaad.2019.01.042_bib23","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1016\/S1470-2045(16)30364-3","article-title":"Avelumab in patients with chemotherapy-refractory metastatic Merkel cell carcinoma: a multicentre, single-group, open-label, phase 2 trial","volume":"17","author":"Kaufman","year":"2016","journal-title":"Lancet Oncol"},{"issue":"26","key":"10.1016\/j.jaad.2019.01.042_bib24","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1056\/NEJMoa1603702","article-title":"PD-1 blockade with pembrolizumab in advanced Merkel-cell carcinoma","volume":"374","author":"Nghiem","year":"2016","journal-title":"N Engl J Med"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962219301495?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962219301495?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:51:05Z","timestamp":1759272665000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962219301495"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":24,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["S0190962219301495"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2019.01.042","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment and survival of Merkel cell carcinoma since 1993: A population-based cohort study in The Netherlands","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2019.01.042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}